The influence of glatiramer acetate on Th17-immune response in multiple sclerosis

Glatiramer acetate (GA) is approved for the treatment of multiple sclerosis (MS). However, the mechanism of action of GA in MS is still unclear. In particular, it is not known whether GA can modulate the pro-inflammatory Th17-type immune response in MS. We investigated the effects of original GA (Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Melnikov, Mikhail, Sharanova, Svetlana, Sviridova, Anastasiya, Rogovskii, Vladimir, Murugina, Nina, Nikolaeva, Anna, Dagil, Yulia, Murugin, Vladimir, Ospelnikova, Tatiana, Boyko, Alexey, Pashenkov, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599084/
https://www.ncbi.nlm.nih.gov/pubmed/33126239
http://dx.doi.org/10.1371/journal.pone.0240305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599084/
https://www.ncbi.nlm.nih.gov/pubmed/33126239
http://dx.doi.org/10.1371/journal.pone.0240305

Ejemplares similares